SCHEMBL24256245

SCHEMBL24256245

O[C@@H]1CN(CC2CCC2)C[C@@H]1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GBA1 P04062 4/20 0.60
▸ CHRM5 P08912 2/20 0.46
▸ ADRA2C P18825 1/20 0.46
▸ SCN1A P35498 1/20 0.43
▸ SCN4A P35499 1/20 0.43
▸ SCN7A Q01118 1/20 0.43
▸ KCNH2 Q12809 1/20 0.43
▸ SCN5A Q14524 1/20 0.43
▸ SCN9A Q15858 1/20 0.43
▸ SCN2A Q99250 1/20 0.43
▸ SCN3A Q9NY46 1/20 0.43
▸ SCN11A Q9UI33 1/20 0.43
▸ SCN8A Q9UQD0 1/20 0.43
▸ SCN10A Q9Y5Y9 1/20 0.43
▸ ACHE P22303 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ CHRM2 P08172 1/20 0.36
▸ CHRM4 P08173 1/20 0.36
▸ CHRM1 P11229 1/20 0.36
▸ SIGMAR1 Q99720 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24008483 0.84 GBA1 (0.70) GBA1CHRM5ADRA2CSCN1ASCN4A
SCHEMBL2716774 0.76 GBA1 (1.00) GBA1
SCHEMBL21003358 0.75 CHRM5 (0.46) GBA1CHRM5ADRA2CSCN1ASCN4A
SCHEMBL20757014 0.75 CHRM5 (0.46) GBA1CHRM5ADRA2CSCN1ASCN4A
SCHEMBL2717184 0.75 GBA1 (0.97) GBA1CHRM5ADRA2C
SCHEMBL26633180 0.75 GBA1 (0.55) GBA1CHRM5ADRA2CSCN1ASCN4A
SCHEMBL26633178 0.75 GBA1 (0.55) GBA1CHRM5ADRA2CSCN1ASCN4A
SCHEMBL26633151 0.75 GBA1 (0.55) GBA1CHRM5ADRA2CSCN1ASCN4A
SCHEMBL14968294 0.74 — —
SCHEMBL20936956 0.73 CHRM5 (0.56) GBA1CHRM5ADRA2CSCN1ASCN4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022035997-A1 IN VIVO ASSEMBLY OF ASGPR BINDING THERAPEUTICS AVILAR THERAPEUTICS, INC. (US) 2022-02-17 — — WO disclosed
Send feedback